Dowsett M - Search Results

1

Clinical strategies for rationale combinations of aromatase inhibitors with novel therapies for breast cancer.

Johnston SR, Martin LA, Leary A, Head J, Dowsett M. Johnston SR, et al. Among authors: dowsett m. J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):180-6. doi: 10.1016/j.jsbmb.2007.05.019. Epub 2007 May 24. J Steroid Biochem Mol Biol. 2007. PMID: 17624764 Review.

2

Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.

Dowsett M, Stein RC, Coombes RC. Dowsett M, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):155-9. doi: 10.1016/0960-0760(92)90201-s. J Steroid Biochem Mol Biol. 1992. PMID: 1388047 Review.

3

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Harper-Wynne C, et al. Among authors: dowsett m. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101108 Clinical Trial.

4

Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.

Chan CM, Martin LA, Johnston SR, Ali S, Dowsett M. Chan CM, et al. Among authors: dowsett m. J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):333-41. doi: 10.1016/s0960-0760(02)00074-2. J Steroid Biochem Mol Biol. 2002. PMID: 12361723

5

Breast cancer: aromatase inhibitors take on tamoxifen.

Dowsett M, Howell A. Dowsett M, et al. Nat Med. 2002 Dec;8(12):1341-4. doi: 10.1038/nm1202-1341. Nat Med. 2002. PMID: 12457166 No abstract available.

6

Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.

Come SE, Buzdar AU, Arteaga CL, Brodie AM, Davidson NE, Dowsett M, Ingle JN, Johnston SR, Lee AV, Osborne CK, Pritchard KI, Vogel VG, Winer EP, Hart CS. Come SE, et al. Among authors: dowsett m. Clin Cancer Res. 2003 Jan;9(1 Pt 2):443S-6S. Clin Cancer Res. 2003. PMID: 12538498 Review. No abstract available.

7

Preoperative models to evaluate endocrine strategies for breast cancer.

Dowsett M. Dowsett M. Clin Cancer Res. 2003 Jan;9(1 Pt 2):502S-10S. Clin Cancer Res. 2003. PMID: 12538507 Review.

8

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S. Clin Cancer Res. 2003. PMID: 12538510 Review.

9

Human epidermal growth factor receptor-2 and hormonal therapies: clinical implications.

Ring A, Dowsett M. Ring A, et al. Among authors: dowsett m. Clin Breast Cancer. 2003 Apr;4 Suppl 1:S34-41. doi: 10.3816/cbc.2003.s.013. Clin Breast Cancer. 2003. PMID: 12756077 Review.

10

Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.

Martin LA, Farmer I, Johnston SR, Ali S, Marshall C, Dowsett M. Martin LA, et al. Among authors: dowsett m. J Biol Chem. 2003 Aug 15;278(33):30458-68. doi: 10.1074/jbc.M305226200. Epub 2003 May 29. J Biol Chem. 2003. PMID: 12775708 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters